Literature DB >> 7092543

Primary melanoma thickness correlated with regional lymph node metastases.

D F Roses, M N Harris, D Hidalgo, Q J Valensi, N Dubin.   

Abstract

We studied 119 patients with stage I primary cutaneous malignant melanoma, who were undergoing regional lymph node dissection, to determine the relationship of lymph node metastases to thickness of the primary lesion. The lymph nodes in the dissection specimen were each evaluated by serial sections. None of the patients with lesions less than 1.0 mm thick had nodal micrometastases. When lesions exceeded 1.0 mm in thickness, there was no appreciable increase in the incidence of nodal metastases until a thickness greater than 4.0 mm was reached, in which cases the incidence of metastases was 50%. Predictive variables were determined by multiple logistic regression analysis. Only lesions that were at least 4.0 mm thick and were not located on the upper extremities were significant predictors of lymph node metastases; within this category there was a 64% incidence of lymph node metastases.

Entities:  

Mesh:

Year:  1982        PMID: 7092543     DOI: 10.1001/archsurg.1982.01380310035008

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  4 in total

Review 1.  Surgical management of metastatic inguinal lymphadenopathy.

Authors:  Marc C Swan; Dominic Furniss; Oliver C S Cassell
Journal:  BMJ       Date:  2004-11-27

2.  Local and in-transit metastases following definitive excision for primary cutaneous malignant melanoma.

Authors:  D F Roses; M N Harris; D Rigel; Z Carrey; R Friedman; A W Kopf
Journal:  Ann Surg       Date:  1983-07       Impact factor: 12.969

3.  Metastasis and death in patients with thin melanomas (less than 0.76 mm).

Authors:  J E Woods; E H Soule; E T Creagan
Journal:  Ann Surg       Date:  1983-07       Impact factor: 12.969

4.  Cutaneous malignant melanoma in West Yorkshire: II. A prospective study of recurrence and prediction of lymph nodal metastasis.

Authors:  J Eastwood; T G Baker
Journal:  Br J Cancer       Date:  1984-07       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.